The effect of strain, growth stage, and cultivating condition of Ganoderma lucidum on 5α-reductase inhibition

Journal of Wood Science

Volumn 51, Issue 2, 2005, Pages 189-192

  Liu, Jie ^a   Fujita, Rumi ^a   Sato, Michiko ^a   Shimizu, Kuniyoshi ^a   Konishi, Fumiko ^b   Noda, Kiyoshi ^b   Kumamoto, Shoichiro ^b   Ueda, Chie ^c   Tajiri, Hisatoshi ^c   Kaneko, Shuhei ^d   Suimi, Yoshitaro ^e   Kondo, Ryuichiro ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b Chlorella Industry Co Ltd   (Japan)

^c Yamaya Conmunications Co Ltd   (Japan)

^d Fukuoka Pref Forest Res Exten C   (Japan)

^e Bisoken and Co Ltd   (Japan)

Author keywords

5 reductase; Anti androgen activities; Benign prostatic hyperplasia (BPH); Ganoderma lucidum

Indexed keywords

CULTIVATION; ENZYMES; EXTRACTION; FRUITS; METHANOL; STRAIN;

FRUITING; GANODERMA LUCIDIUM; GROWTH STAGE; MYCELIA;

WOOD;

CULTIVATION; ENZYMES; EXTRACTION; FRUITS; METHANOL; STRAINS; WOOD;

GANODERMA LUCIDUM;

EID: 21044441797     PISSN: 14350211     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10086-004-0645-z     Document Type: Article

References (13)

1. Wasser SP, Weis AL (1999) Therapeutic effects of substances occurring in higher Basidiomycetes mushrooms: a modern perspective. Crit Rev Immunol 19:65-96
2. Barrtsch G, Rittmaster RS, Klocker H (2002) Dihydrotestosterone and the concept of 5α-reductase inhibition on human benign prostatic hyperplasia. World J Urol 19:413-425
3. Russell DW, Wilson JD (1994) Steroid 5α-reductase: two genes/two enzymes. Annu Rev Biochem 63:25-61
4. Jenkins EP, Hsieh CL, Milatovitch A, Normington K, Berman DM, Francke U, Russell DW (1991) Characterization and chromosomal mapping of a human steroid 5α-reductase gene and pseudogene and mapping of the mouse homolog. Genomics 11:1102-1112
5. Iehle C, Radvanyi F, Gil Diez de Medina S, Ouafik LH, Gerard H, Chopin D, Raynaud JP, Martin PM (1999) Differences in steroid 5α-reductase iso-enzymes expression between normal and pathological human prostate tissue. J Steroid Biochem 68:189-195
6. Bartsch G, Rittmaster RS, Klocker H (2000) Dihydrotestosterone and the concept of 5 alpha-reductase inhibition in human benign prostatic hyperplasia. Eur Urol 37:367-380
7. Uygur MC, Gur E, Ariki AI, Altug U, Erol D (1998) Erectile dysfunction following treatments of benign prostatic hyperplasia: a prospective study. Andrologia 30:5-10
8. Yun TK (1999) Update from Asia. Asian studies on cancer chemoprevention. Ann NY Acad Sci 889:157-192
9. Shimizu K, Fukuda M, Kondo R, Sakai K (2000) The 5α-reductase inhibitory components from heartwood of Artocarpus incisus: structure-activity investigations. Planta Med 66:16-19
10. Andersson S, Russell DW (1990) Structural and biochemical properties of cloned and expressed human and rat steroid 5α-reductases. Proc Natl Acad Sci USA 87:3640-3644
11. Mizushina Y, Hanashima L, Yamaguchi T, Takemura M, Sugawara F, Saneyoshi M, Matsukage A, Yoshida S, Sakaguchi K (1998) A mushroom fruiting body-inducing substance inhibits activities of replicative DNA polymerases. Biochem Biophys Res Commun 249:17-22
12. Min BS, Gao JJ, Nakamura N, Hattori M (2000) Triterpenes from the spores of Ganoderma lucidum and their cytotoxicity against meth-A and LLC tumor cells. Chem Pharm Bull 48:1026-1033
13. Graul A, Silvestre J, Castaner J, Dutasteride (1999) Steroid 5α-reductase inhibitor treatment of BPH. Drugs Fut 24:246-253